Search Results - "HONG, Borah"

Early Clinical Experience with Dapagliflozin in Children with Heart Failure by Newland, David M., Law, Yuk M., Albers, Erin L., Friedland-Little, Joshua M., Ahmed, Humera, Kemna, Mariska S., Hong, Borah J.

“…Pediatric heart failure (HF) is associated with significant morbidity and mortality. Medical treatment for pediatric HF is largely derived from adult studies…”
Get full text

Assessment of the adverse effects of sirolimus versus everolimus in pediatric heart transplant recipients by Newland, David M., Rosete, Beatrice E., Law, Yuk M., Kemna, Mariska S., Albers, Erin L., Hong, Borah J., Ahmed, Humera, Spencer, Kathryn L., Friedland‐Little, Joshua M.

“…Background Literature is limited comparing adverse effects (AEs) of the proliferation signal inhibitors (PSIs) sirolimus (SRL) and everolimus (EVL) in…”
Get full text

External assessment and refinement of a population pharmacokinetic model to guide tacrolimus dosing in pediatric heart transplant by Rower, Joseph E., McKnite, Autumn, Hong, Borah, Daly, Kevin P., Hope, Kyle D., Cabrera, Antonio G., Molina, Kimberly M.

“…Study Objective The immunosuppressant tacrolimus is a first‐line agent to prevent graft rejection following pediatric heart transplant; however, it suffers…”
Get full text

Impact of preoperative risk factors on outcomes after Norwood palliation for hypoplastic left heart syndrome by Shamszad, Pirouz, MD, Gospin, Tal A., MD, Hong, Borah J., MD, McKenzie, Emmett D., MD, Petit, Christopher J., MD

“…Background Infants with hypoplastic left heart syndrome (HLHS) are susceptible to pre-Norwood comorbidities (PCs) and complications. This study aimed to…”
Get full text

Dapagliflozin Use in Children with Advanced Heart Failure Undergoing Heart Transplantation: A Matched Case-Control Study by Newland, David M, Law, Yuk M, Albers, Erin L, Ali, Reda, Friedland-Little, Joshua M, Hartje-Dunn, Christina, Kemna, Mariska S, Knorr, Lisa R, Nemeth, Thomas L, Spencer, Kathryn L, Hong, Borah J

“…Dapagliflozin has been associated with euglycemic ketoacidosis in adults with diabetes contributing to poor outcomes when continued prior to surgery. It is…”
Get full text

Analysis of Platelet Function Testing in Children Receiving Aspirin for Antiplatelet Effects by Newland, David M., Palmer, Michelle M., Knorr, Lisa R., Pak, Jennifer L., Albers, Erin L., Friedland-Little, Joshua M., Hong, Borah J., Law, Yuk M., Spencer, Kathryn L., Kemna, Mariska S.

“…Aspirin (ASA) remains the most common antiplatelet agent used in children. VerifyNow Aspirin Test® (VN) assesses platelet response to ASA, with therapeutic…”
Get full text

A quantitative assessment of renal function utilizing albuminuria in pediatric heart transplant recipients by Frandsen, Erik L., Kronmal, Richard A., Albers, Erin A., Friedland‐Little, Joshua M., Hong, Borah J., Spencer, Katherine L., Hingorani, Sangeeta R., Law, Yuk M.

“…Introduction Kidney disease is common after pediatric heart transplantation. Serum creatinine‐based glomerular filtration rate is the most frequently reported…”
Get full text

Impact of postoperative nutrition on weight gain in infants with hypoplastic left heart syndrome by Hong, Borah J., MD, Moffett, Brady, PharmD, MPH, Payne, William, BS, Rich, Sundae, MS, RD, Ocampo, Elena C., MD, Petit, Christopher J., MD

“…Objective The study objective was to evaluate risk factors for poor weight gain in infants with hypoplastic left heart syndrome after stage 1 palliation…”
Get full text

Iron Laboratory Studies in Pediatric Patients With Heart Failure from Dilated Cardiomyopathy by Higgins, David, Otero, Jessica, Jefferis Kirk, Christa, Pak, Jennifer, Jorgensen, Neal, Kemna, Mariska, Albers, Erin, Hong, Borah, Friedland-Little, Joshua, Law, Yuk

“…Iron deficiency (FeD), with or without anemia, in adults with heart failure (HF) is associated with poor outcomes, which can be improved with replacement…”
Get full text

Mycophenolic acid therapeutic drug monitoring using area under the curve in pediatric heart transplant recipients by Newland, David M, Pak, Jennifer L, Ali, Reda, Herzog, Thiebaut, Nemeth, Thomas L, Tressel, William, Kronmal, Richard A, Knorr, Lisa R, Albers, Erin L, Friedland-Little, Joshua M, Ahmed, Humera, Kemna, Mariska S, Hong, Borah J, Spencer, Kathryn, Law, Yuk M

“…Pharmacokinetics of mycophenolic acid (MPA) display substantial interpatient variability, with up to 10-fold difference of exposure in individual patients…”
Get full text

Prevalence of iron deficiency and anemia in pediatric heart transplant recipients by Newland, David M., Spencer, Kathryn L., Do, Long D., Knorr, Lisa R., Palmer, Michelle M., Albers, Erin L., Friedland‐Little, Joshua M., Hong, Borah J., Kemna, Mariska S., Hartje‐Dunn, Christina, Mark, Dominique G., Nemeth, Thomas L., Ravi‐Johnson, Sara, Law, Yuk M.

“…Introduction The prevalence of iron deficiency and anemia in the setting of modern‐day maintenance immunosuppression in pediatric heart transplant (HTx)…”
Get full text

Human leukocyte antigen eplet mismatching is associated with increased risk of graft loss and rejection after pediatric heart transplant by Albers, Erin L., Friedland‐Little, Joshua M., Hong, Borah J., Kemna, Mariska S., Warner, Paul, Law, Yuk M.

“…Background While mismatching between donor and recipient human leukocyte antigen (HLA) alleles has been associated with increased graft loss in pediatric heart…”
Get full text

Changes in renal function after left ventricular assist device placement in pediatric patients: A Pedimacs analysis by Friedland-Little, Joshua M., Hong, Borah J., Gossett, Jeffrey G., Deshpande, Shriprasad R., Law, Sabrina, Hollifield, Kathryn A., Cantor, Ryan S., Koehl, Devin, Kindel, Steven J., Turrentine, Mark W., Davies, Ryan R.

“…Renal dysfunction (RD) is prevalent among pediatric patients with advanced heart failure. Data are limited regarding changes in renal function after left…”
Get full text

Outcomes of low-intensity biopsy surveillance for rejection in paediatric cardiac transplantation by Evers, Patrick D, Jorgensen, Neal, Hong, Borah, Albers, Erin, Kemna, Mariska, Friedland-Little, Josh, Boucek, Robert J, Law, Yuk

“…Significant inter-centre variability in the intensity of endomyocardial biopsy surveillance for rejection following paediatric cardiac transplantation has been…”
Get more information

Waitlist and posttransplant outcomes of critically ill infants awaiting heart transplantation managed without ventricular assist device support by Frandsen, Erik L., Banker, Katherine A., Mazor, Robert L., McMullan, D. Michael, Law, Yuk M., Kemna, Mariska S., Albers, Erin L., Hong, Borah J., Friedland‐Little, Joshua M.

“…Background Infants listed for heart transplant are at high risk for waitlist mortality. While waitlist mortality for children has decreased in the current era…”
Get full text

Left ventricular non-compaction cardiomyopathy in children listed for heart transplant: Analysis from the Pediatric Heart Transplant Study Group by Lal, Ashwin K., MD, Pruitt, Elizabeth, MSPH, Hong, Borah J., MD, Lin, Kimberly Y., MD, Feingold, Brian, MD, MS

Get full text

Donor‐specific anti‐HLA antibody production following pediatric ABO‐incompatible heart transplantation by Chen, Chiu‐Yu, Warner, Paul, Albers, Erin L., Kemna, Mariska S., Delaney, Meghan, Hong, Borah J., Law, Yuk M.

“…ABO‐i heart transplantation can be performed in infants with end‐stage heart failure to increase organ availability. The development of newly detected DSAs is…”
Get full text

A fatal case of bortezomib‐induced lung toxicity in a young adult heart transplant recipient by Frandsen, Erik L., Otero, Jessica, Rutledge, Joe C., Kemna, Mariska S., Albers, Erin L., Hong, Borah J., Law, Yuk M., Friedland‐Little, Joshua M.

“…Bortezomib is approved for the treatment of multiple myeloma but increasingly used in heart transplant (HTx) recipients with antibody‐mediated rejection (AMR)…”
Get full text

Assessment of rejection risk following subtherapeutic calcineurin inhibitor levels after pediatric heart transplantation by Kerr, Sarah M., Jorgensen, Neal W., Hong, Borah J., Friedland‐Little, Joshua M., Albers, Erin L., Newland, David M., Law, Yuk M., Kemna, Mariska S.

“…CNIs are the mainstay of immunosuppressive therapy after pediatric HTx. While regular laboratory surveillance is performed to ensure blood levels are within…”
Get full text

RISK FACTORS FOR SUDDEN DEATH IN CHILDREN WITH CARDIAC ALLOGRAFT VASCULOPATHY by Hong, Borah J, Sexson, Kristen, Jeewa, Aamir, Cabrera, Antonio, Price, Jack, Heinle, Jeffrey, Dreyer, William, Denfield, Susan

Get full text